Tijaria Polypipes Intrinsic Value
Tijaria Polypipes (TIJARIA) median intrinsic value is ₹11.30 from 1 valuation models (range ₹11–₹11), vs current price ₹4.52 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Analyse TIJARIA institutional holdings to track promoter, FII and institutional holdings.
TIJARIA Valuation Methods Summary — DCF, Graham Number & P/E
Tijaria Polypipes intrinsic value across 1 models vs current price ₹4.52 — upside/downside and value range per method. Read TIJARIA dividend yield for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Simple DCF (5Y) | dcf | ₹11.30 | ₹9.04 - ₹13.56 | +150.0% | CF Growth: 15.0%, Discount: 15% |
TIJARIA Intrinsic Value vs Market Price — All Valuation Models
Tijaria Polypipes fair value range ₹11–₹11 vs current market price ₹4.52 across 1 valuation models. For current market price and key ratios, visit Tijaria Polypipes stock price NSE.
TIJARIA Intrinsic Value Analysis — Undervalued or Overvalued?
Tijaria Polypipes median intrinsic value ₹11.30, current price ₹4.52 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of TIJARIA?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Tijaria Polypipes (TIJARIA) is ₹11.30 (median value). With the current market price of ₹4.52, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹11.30 to ₹11.30, indicating ₹11.30 - ₹11.30.
Is TIJARIA undervalued or overvalued?
Based on our multi-method analysis, Tijaria Polypipes (TIJARIA) appears to be trading below calculated value by approximately 150.0%.
TIJARIA Financial Health — Key Ratios vs Industry Benchmarks
Tijaria Polypipes financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.57 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 2.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
TIJARIA Cash Flow Quality — Operating & Free Cash Flow
Tijaria Polypipes operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹5 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |